![]() |
市場調查報告書
商品編碼
1478061
全球自動化細胞成像系統市場規模、佔有率、成長分析,按產品、最終用戶、應用、技術、地區 - 產業預測,2024-2031Global Automated Cell Imaging System Market Size, Share, Growth Analysis, By Product, By End users, By Application, By Technology, By Region - Industry Forecast 2024-2031 |
自動化細胞成像系統的全球市場規模,2022年價值 1,089 億美元,預計將從2023年的1,183.7億美元成長到2031年的2,307.2億美元,預測期內(2024-2031年)年複合成長率為8.7%。
預計市場將以更快、更健康的速度擴張。因為世界上患有慢性病的人比以往任何時候都多。此外,加大新藥、疫苗研發投入也支持市場拓展。然而,由於高昂的維護成本和缺乏更換零件,自動細胞成像系統的市場並未如預期擴大。從全球來看,北美所佔比例最高。這得益於醫療產業較早採用最尖端科技。美國是這一領域的領先國家。由於醫療保健領域的大量投資,亞太地區迅速擴張。
Global Automated Cell Imaging System Market size was valued at USD 108.9 billion in 2022 and is poised to grow from USD 118.37 billion in 2023 to USD 230.72 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).
The market is anticipated to expand more quickly and at a healthier rate. It is because there are more chronic patients in the world than ever before. The expansion of the market is also being driven by increased investments in research and development of novel medications and vaccines. Nevertheless, the market for automated cell imaging systems is not expanding as quickly as it should due to high maintenance costs and a lack of replacement parts. Globally, North America has the largest proportion. The early adoption of cutting-edge technologies in the healthcare industry is to blame. The United States is the main nation in the area. Due to significant investment in the healthcare sector, the Asia-Pacific area is expanding at a quicker rate.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Automated Cell Imaging System Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Automated Cell Imaging System Market Segmental Analysis
The global automated cell imaging system is categorized on the basis of product, end-user, technology, and region. With respect to segmentation by product, the market is grouped into time lapse, colocalization, and others. In terms of classification by end user, the market is segmented into hospitals, and research and diagnostic laboratories. On the basis of application, the market is segmented into live cell vivo imaging, and screening. Based on technology, the market is classified into fluorescence, luminescence, phase contrast, and others. Geographically, the market is segmented into Asia Pacific, Europe, North America, Middle East & Africa, and Latin America.
Drivers of the Global Automated Cell Imaging System Market
Our body exhibits certain genetic abnormalities as a result of radiation and lifestyle changes. This results in aberrant cell division, which causes tumors. Cancer is also brought on by specific chemicals that are exposed to food, water, and soil. In order to determine the dynamics and activities of telomeric repeat-containing RNA, automated cell imaging methods are also necessary for the development of novel cancer kinds. With the ability to examine digitized microscopic images of malignant cells, automated cell imaging is a novel and increasingly popular method for cellular research.
Restraints in the Global Automated Cell Imaging System Market
When an automated cell imaging system is destroyed, its spare parts must be completely replaced, which comes at a very high cost. It's because there is a supply side shortfall caused by the small number of manufacturers of this product. Additionally, the setup costs are relatively significant. Its operation also necessitates considerable electricity.
Market Trends of the Global Automated Cell Imaging System Market
Large pharmaceutical companies are heavily investing in new technology in an effort to develop new medications and vaccines. In long-term experiments, huge chemical libraries, or both, automated cell imaging methods reduce human error and the amount of time required for human intervention. High-resolution photos are collected and analyzed by the system.